Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Multidrug Resistance After Trabeculectomy With Mitomycin C

This study has been completed.
Information provided by:
University of Cologne Identifier:
First received: March 19, 2007
Last updated: March 23, 2007
Last verified: March 2007
We investigate whether mitomycin C treatment during previous filtration surgery induces P-glycoprotein expression.


Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Multidrug Resistance After Trabeculectomy With Mitomycin C

Resource links provided by NLM:

Further study details as provided by University of Cologne:

Estimated Enrollment: 30
Detailed Description:
Despite the adjuvant use of mitomycin C during trabeculectomy, short-term and long-term failures still occur. We investigate whether mitomycin C treatment during previous trabeculectomy induces P-glycoprotein expression. Expression of P-glycoprotein is analysed in surgically removed Tenon tissue using immunohistochemistry.

Ages Eligible for Study:   8 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients with planned trabeculectomy for elevated eye pressure
  • one third of patients without previous trabeculectomy
  • two thirds of patients with previous trabeculectomy (one third with and one third without the use of mitomycin C)

Exclusion Criteria:

  • patients not requiring surgery
  • patients with planned surgery for elevated eye pressure other than trabeculectomy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00449631

The University Hospital of Cologne
Cologne, Germany, 50924
Sponsors and Collaborators
University of Cologne
Principal Investigator: Arno Hueber, MD University of Cologne
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00449631     History of Changes
Other Study ID Numbers: Multidrug Resistance
Study First Received: March 19, 2007
Last Updated: March 23, 2007

Keywords provided by University of Cologne:
Drug Resistance, Multiple

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases
Antibiotics, Antineoplastic
Antineoplastic Agents
Alkylating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Enzyme Inhibitors processed this record on May 23, 2017